Norris Medicines Ltd Q2 FY2024-2025 Results: Summary
Revenue | ₹1.27Cr |
Net Profits | ₹0.36Cr |
Net Profit Margins | -28.35% |
Highlights
Revenue:
Norris Medicines Ltd’s revenue fell -50.39% since last year same period to ₹1.27Cr in the Q2 2024-2025. On a quarterly growth basis, Norris Medicines Ltd has generated 71.62% jump in its revenue since last 3-months.
Net Profits:
Norris Medicines Ltd’s net profit jumped 25% since last year same period to ₹0.36Cr in the Q2 2024-2025. On a quarterly growth basis, Norris Medicines Ltd has generated 2.7% jump in its net profits since last 3-months.
Net Profit Margins:
Norris Medicines Ltd’s net profit margin fell -51.18% since last year same period to -28.35% in the Q2 2024-2025. On a quarterly growth basis, Norris Medicines Ltd has generated 43.31% jump in its net profit margins since last 3-months.
